Aditx Therapeutics to Present at H.C. Wainwright 22nd Annual Global Investment Conference
September 10 2020 - 4:30PM
via NEWMEDIAWIRE -- Aditx Therapeutics, Inc. (Aditxt) (the
"Company") (NASDAQ:ADTX), a life sciences company developing
biotechnologies focused on improving the health of the immune
system through immune monitoring and reprogramming, today announced
that it will be presenting at the H.C. Wainwright 22nd Annual
Global Investment Conference being held virtually from September
14-16, 2020. The presentation is scheduled for Wednesday, September
16th at 3:00 PM EDT.
Amro Albanna, Co-founder and Chief Executive
Officer of Aditxt, will be presenting a corporate overview to a
live audience and will be available for virtual one-on-one meetings
with investors throughout the conference.
The presentation will be webcast live and may be accessed by
following this link: https://wsw.com/webcast/hcw7/adtx/1609577
About Aditx Therapeutics
Aditxt is developing technologies specifically
focused on improving the health of the immune system through immune
monitoring and reprogramming. The immune monitoring technology is
designed to provide a personalized comprehensive profile of the
immune system. The immune reprogramming technology is currently at
the pre-clinical stage and is designed to retrain the immune system
to induce tolerance with an objective of addressing rejection of
transplanted organs, autoimmune diseases, and allergies. For more
information, please visit www.aditxt.com.
Forward-Looking Statements
Certain statements in this press release
constitute “forward-looking statements” within the meaning of the
federal securities laws. Forward-looking statements include
statements regarding the Company’s intentions, beliefs,
projections, outlook, analyses or current expectations concerning,
among other things, the Company’s ongoing and planned product
development; the Company’s intellectual property position; the
Company’s ability to develop commercial functions; expectations
regarding product launch and revenue; the Company’s results of
operations, cash needs, spending, financial condition, liquidity,
prospects, growth and strategies; the industry in which the Company
operates; and the trends that may affect the industry or the
Company. Forward-looking statements are not guarantees of future
performance and actual results may differ materially from those
indicated by these forward-looking statements as a result of
various important factors, as well as those risks more fully
discussed in the section entitled “Risk Factors” in the Company’s
prospectus, dated September 1, 2020, that was filed with the U.S.
Securities and Exchange Commission under File No. 333-248491, as
well as discussions of potential risks, uncertainties, and other
important factors in the Company’s subsequent filings with the U.S.
Securities and Exchange Commission. All such statements speak only
as of the date made, and the Company undertakes no obligation to
update or revise publicly any forward-looking statements, whether
as a result of new information, future events or otherwise.
Investor Relations Contact: PCG
Advisory Jeff Ramson Chief Executive Officer 646-762-4518
IR@aditxt.com www.aditxt.com
Aditxt (NASDAQ:ADTX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Aditxt (NASDAQ:ADTX)
Historical Stock Chart
From Apr 2023 to Apr 2024